Two-Year Follow-Up After Endovascular Therapy of Superficial Femoral Arteries with Retrograde Popliteal Approach: Single-Center Experience
Keywords:Endovascular treatment, retrograde popliteal access, superficial femoral artery, long term patenc
Objective: Popliteal artery puncture, which makes possible the use of lower profile sheaths and devices, has gained popularity as an alternative to the antegrade approach, due to the reduction in vascular complications at the access site. The present study aimed to analyze the safety of the procedure and long-term patency of the superficial femoral artery (SFA) and popliteal artery (PA) and in subjects undergoing recanalization with the popliteal retrograde approach.
Methods: Forty-three subjects, who underwent endovascular therapy (EVT) of the SFA or PA with retrograde popliteal approach, were enrolled in this retrospective study. The decision for the retrograde approach was made according to pre-intervention CT angiography results (severe calcification and relatively long CTO segment) in 20 of the subjects. The remaining 23 subjects underwent SFA or PA recanalization with the retrograde approach, due to failed antegrade recanalization attempt. All patients underwent color duplex ultrasound at the first, sixth, 12th, and 24th months to determine patency. The rate of procedural complications, including hematoma, bleeding, and distal embolism, were recorded for all subjects.
Results: Technical success was achieved in all cases. Access site complications, including hematoma and bleeding, were observed in 2 subjects (4.66%). Transfusion or surgical treatments were not required in any cases with access site complications. The acute success rate was defined as the recovery of good blood flow evaluated by angiography after EVT was 100%. Distal embolization, which did not cause any limitations in distal flow, occurred in 1 subject (2.33%). Ankle-brachial index (ABI) calculated at 1 month post-intervention was significantly higher than pre-intervention ABI [0.9 (0.59 - 1.3) versus 0.7 (0.4 - 1.1), P < .001]. Patency rates, as determined by ultrasonographic assessment at post-interventional first, sixth, 12th, and 24th months, were 100%, 95.34%, 88.37%, and 86.04%, respectively.
Conclusion: Our findings demonstrate that retrograde popliteal artery puncture can be used as a safe and effective technique for recanalization of SFA and PA stenosis and occlusions. The retrograde popliteal approach provides excellent long-term primary patency rates.
Ansari F, Pack LK, Brooks SS, Morrison TM. 2013. Design considerations for studies of the biomechanical environment of the femoropopliteal arteries. J Vasc Surg 58(3): 804-13.
Banerjee S. 2016. Superficial Femoral Artery Is Not Left Anterior Descending Artery. Circulation 134(13): 901-3.
Brountzos EN, Moulakakis KG, Avgerinos ED, Dalainas I, T GG, Kakisis J, et al. 2011. Retrograde transpopliteal approach of iliofemoral lesions. Vascular and endovascular surgery 45(7): 646-50.
Conrad MF, Cambria RP, Stone DH, Brewster DC, Kwolek CJ, Watkins MT, et al. 2006. Intermediate results of percutaneous endovascular therapy of femoropopliteal occlusive disease: a contemporary series. J Vasc Surg 44(4): 762-9.
Dumantepe M. 2017. Retrograde Popliteal Access to Percutaneous Peripheral Intervention for Chronic Total Occlusion of Superficial Femoral Arteries. Vascular and endovascular surgery 51(5): 240-46.
Goltz JP, Kleemann M. 2015. Complex recanalization techniques for complex femoro-popliteal lesions: how to optimize outcomes. J Cardiovasc Surg (Torino) 56(1): 31-41.
Heenan SD, Vinnicombe SJ, Buckenham TM, Belli AM. 1994. Percutaneous transluminal angioplasty by a retrograde subintimal transpopliteal approach. Clin Radiol 49(11): 824-7; discussion 27-8.
Henry M, Amicabile C, Amor M, Beron R, Henry I, Mentre B. 1993. [Peripheral arterial angioplasty: value of the popliteal approach. Apropos of 30 cases]. Archives des maladies du coeur et des vaisseaux 86(4): 463-9. 1993/04/01.
Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. 2006. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 113(11): e463-654.
Kawarada O. 2011. Commentary: Miniaturized retrograde popliteal approach in a supine patient. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 18(4): 510-2.
Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. 2007. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 45 Suppl S: S5-67.
Saha S, Gibson M, Magee TR, Galland RB, Torrie EP. 2001. Early results of retrograde transpopliteal angioplasty of iliofemoral lesions. Cardiovasc Intervent Radiol 24(6): 378-82.
Schmidt A, Bausback Y, Piorkowski M, Werner M, Braunlich S, Ulrich M, et al. 2012. Retrograde recanalization technique for use after failed antegrade angioplasty in chronic femoral artery occlusions. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 19(1): 23-9.
Trigaux JP, Van Beers B, De Wispelaere JF. 1991. Anatomic relationship between the popliteal artery and vein: a guide to accurate angiographic puncture. AJR Am J Roentgenol 157(6): 1259-62.
Ueshima D, Ashikaga T, Shimura T, Hatano Y, Sasaoka T, Kurihara K, et al. 2015. Popliteal Retrograde Approach is Effective and Safe for Superficial Femoral Artery Chronic Total Occlusion. Ann Vasc Dis 8(3): 220-6.
Wojtasik-Bakalarz J, Arif S, Chyrchel M, Rakowski T, Bartus K, Dudek D, et al. 2017. Twelve months follow-up after retrograde recanalization of superficial femoral artery chronic total occlusion. Postepy Kardiol Interwencyjnej 13(1): 47-52.
Yahagi K, Otsuka F, Sakakura K, Sanchez OD, Kutys R, Ladich E, et al. 2014. Pathophysiology of superficial femoral artery in-stent restenosis. J Cardiovasc Surg (Torino) 55(3): 307-23.
Ye M, Zhang H, Huang X, Shi Y, Yao Q, Zhang L, et al. 2013. Retrograde popliteal approach for challenging occlusions of the femoral-popliteal arteries. J Vasc Surg 58(1): 84-9.
Yilmaz S, Sindel T, Luleci E. 2005. Ultrasound-guided retrograde popliteal artery catheterization: experience in 174 consecutive patients. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 12(6): 714-22.
Zaitoun R, Iyer SS, Lewin RF, Dorros G. 1990. Percutaneous popliteal approach for angioplasty of superficial femoral artery occlusions. Catheterization and cardiovascular diagnosis 21(3): 154-8.
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).